Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Bruce R Brodie Added: 3 years ago
Abstract This article reviews optimum therapies for the management of ST-elevation myocardial infarction (STEMI) with primary percutaneous coronary intervention (PCI). Optimum anti-thrombotic therapy includes aspirin, bivalirudin and the new anti-platelet agents prasugrel or ticagrelor. Stent thrombosis (ST) has been a major concern but can be reduced by achieving optimal stent deployment, use… View more

Vascular Disease and Surgery

Prevention & Chronic Conditions
Evaluating the Impact of COVID-19 on a Regional pPCI Service
Author(s): Adeogo Akinwale Olusan , Peadar Devlin Added: 2 years ago

COVID-19

MI/ACS
Author(s): Giancarlo Marenzi , Antonio L Bartorelli Added: 3 years ago
Primary angioplasty represents the best available strategy for treatment of ST-segment elevation myocardial infarction (STEMI).1 However, its application in patients with chronic kidney disease is particularly problematic and not well characterised. One of the main reasons for this is that such patients have typically been excluded from clinical trials evaluating the outcome of coronary… View more

Imaging & Diagnostics

MI/ACS
Author(s): Petr Kala Added: 3 years ago
Patients suffering acute myocardial infarction with ST-segment elevation (STEMI) require full attention of the whole STEMI network to save their lives and to improve the quality of life after a heart attack. Close cooperation among all stakeholders on a national and regional level has to be established. The emergency medical service (EMS) and direct transportation to the 24 hours a day, seven… View more

Standards & Guidelines

Prevention & Chronic Conditions
Management of Acute Coronary Syndromes During the Coronavirus Disease 2019 Pandemic: Deviations from Guidelines and Pragmatic Considerations for Patients and Healthcare Workers
Author(s): Henry Seligman , Sayan Sen , Sukhjinder Nijjer , et al Added: 3 years ago
International guidelines provide clinicians with evidence-based recommendations on how to manage patients presenting with acute coronary syndromes (ACS). Guidance includes the appropriateness and optimal timing for percutaneous interventions as well as the ideal length of hospital stay.1–5 However, the current global pandemic of coronavirus disease 2019 (COVID-19), has posed an unprecedented… View more

COVID-19
Author(s): Kristina Grønborg Laut , Alma Becic Pedersen , Timothy L Lash , et al Added: 3 years ago
Coronary heart disease (CHD) remains a leading cause of mortality and disability for both men and women in Europe, accounting for 1.92 million deaths each year.1 One in five women (22%) and one in five men (21%) die from the disease.1 This significant burden necessitates ongoing improvements in patient management and treatment, to minimise the impact of cardiovascular conditions on both patients… View more

Standards & Guidelines

Prevention & Chronic Conditions
Author(s): Matthias Hasun , Franz Weidinger Added: 3 years ago
For ST-segment elevation myocardial infarction (STEMI), there is currently no doubt that primary percutaneous coronary intervention (PPCI) of the infarct related artery (IRA) is the preferred reperfusion strategy.1 In about 50% of cases, STEMI is associated with multivessel coronary artery disease (MVCAD), defined as a ≥50% stenosis in at least one non-infarct related epicardial coronary artery … View more

Prevention & Chronic Conditions
Author(s): Navin K Kapur Added: 3 years ago

Heart Failure

MI/ACS
Left Ventricular Unloading and Delaying Coronary Reperfusion Preserves Energy Substrate Utilisation and Protects Mitochondrial Integrity in a Pre-clinical Model of Acute MI
Author(s): Lija Swain Added: 4 years ago

MI/ACS
Combining Venoarterial Extracorporeal Membrane Oxygenation and Impella (ECPELLA) Before Reperfusion Mitigates Left Ventricular Loading and Injury Due to VA-ECMO in Acute MI
Author(s): Kay Everett Added: 1 year ago

Heart Failure